| Year |
Citation |
Score |
| 2021 |
Romo-Nava F, Blom T, Cuellar-Barboza AB, Awosika OO, Martens BE, Mori NN, Colby CL, Prieto ML, Veldic M, Singh B, Gardea-Resendez M, Nunez NA, Ozerdem A, Biernacka JM, Frye MA, et al. Revisiting the bipolar disorder with migraine phenotype: Clinical features and comorbidity. Journal of Affective Disorders. 295: 156-162. PMID 34464877 DOI: 10.1016/j.jad.2021.08.026 |
0.304 |
|
| 2021 |
Lin Y, Maihofer AX, Stapp E, Ritchey M, Alliey-Rodriguez N, Anand A, Balaraman Y, Berrettini WH, Bertram H, Bhattacharjee A, Calkin CV, Conroy C, Coryell W, D'Arcangelo N, DeModena A, ... ... Frye M, et al. Clinical Predictors of Non-Response to Lithium Treatment in The Pharmacogenomics of Bipolar Disorder (PGBD) Study. Bipolar Disorders. PMID 33797828 DOI: 10.1111/bdi.13078 |
0.31 |
|
| 2020 |
Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Cearns M, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu YH, Shekhtman T, Adli M, Akula N, Akiyama K, Ardau R, ... ... Frye MA, et al. Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Molecular Psychiatry. PMID 32203155 DOI: 10.1038/S41380-020-0689-5 |
0.315 |
|
| 2019 |
Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CMR, Post R. Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants. Focus (American Psychiatric Publishing). 17: 322-324. PMID 32015724 DOI: 10.1176/appi.focus.17307 |
0.317 |
|
| 2019 |
Pilhatsch M, J Stamm T, Stahl P, Lewitzka U, Berghöfer A, Sauer C, Gitlin M, Frye MA, Whybrow PC, Bauer M. Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptoms. International Journal of Bipolar Disorders. 7: 21. PMID 31583561 DOI: 10.1186/s40345-019-0155-y |
0.332 |
|
| 2019 |
Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, Power RA, Ripke S, Stahl EA, Starnawska A, Anjorin A, Corvin A, Sanders AR, Forstner AJ, ... ... Frye M, et al. GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores. The American Journal of Psychiatry. appiajp201918080957. PMID 31164008 DOI: 10.1176/Appi.Ajp.2019.18080957 |
0.307 |
|
| 2018 |
Winham SJ, Bobo WV, Liu J, Coombes B, Backlund L, Frye MA, Biernacka JM, Schalling M, Lavebratt C. Sex-specific effects of gain-of-function P2RX7 variation on bipolar disorder. Journal of Affective Disorders. 245: 597-601. PMID 30445384 DOI: 10.1016/J.Jad.2018.11.007 |
0.333 |
|
| 2018 |
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Nolen WA. More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring. European Archives of Psychiatry and Clinical Neuroscience. PMID 30099616 DOI: 10.1007/S00406-018-0934-Y |
0.312 |
|
| 2018 |
Post RM, McElroy S, Kupka R, Suppes T, Hellemann G, Nolen W, Frye M, Keck P, Grunze H, Rowe M. Axis II Personality Disorders Are Linked to an Adverse Course of Bipolar Disorder. The Journal of Nervous and Mental Disease. PMID 29781886 DOI: 10.1097/Nmd.0000000000000819 |
0.332 |
|
| 2018 |
Ahmed AT, Weinshilboum R, Frye MA. Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder. Clinical Pharmacology and Therapeutics. PMID 29388201 DOI: 10.1002/cpt.1009 |
0.303 |
|
| 2017 |
Sanacora G, Frye MA, McDonald W, Mathew SJ, Turner MS, Schatzberg AF, Summergrad P, Nemeroff CB. A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders. Jama Psychiatry. PMID 28249076 DOI: 10.1001/jamapsychiatry.2017.0080 |
0.315 |
|
| 2017 |
Post RM, Altshuler LL, Kupka R, McElroy SL, Frye MA, Rowe M, Grunze H, Suppes T, Keck PE, Leverich GS, Nolen WA. More childhood onset bipolar disorder in the United States than Canada or Europe: Implications for treatment and prevention. Neuroscience and Biobehavioral Reviews. PMID 28119069 DOI: 10.1016/J.Neubiorev.2017.01.022 |
0.31 |
|
| 2016 |
Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, Bhattacharjee A, Brennand KJ, Burdick KE, Calabrese JR, Calkin CV, Claasen A, Coryell WH, Craig D, DeModena A, ... Frye M, et al. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. Bmc Psychiatry. 16: 129. PMID 27150464 DOI: 10.1186/S12888-016-0732-X |
0.348 |
|
| 2016 |
Miller S, Suppes T, Mintz J, Hellemann G, Frye MA, McElroy SL, Nolen WA, Kupka R, Leverich GS, Grunze H, Altshuler LL, Keck PE, Post RM. Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network. The American Journal of Psychiatry. appiajp201615091119. PMID 27079133 DOI: 10.1176/Appi.Ajp.2016.15091119 |
0.312 |
|
| 2016 |
Bobo WV, Voort JL, Croarkin PE, Leung JG, Tye SJ, Frye MA. KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE. Depression and Anxiety. PMID 27062450 DOI: 10.1002/da.22505 |
0.301 |
|
| 2016 |
Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA. Clinical correlates of sustained response to individual drugs used in naturalistic treatment of patients with bipolar disorder. Comprehensive Psychiatry. 66: 146-156. PMID 26995248 DOI: 10.1016/J.Comppsych.2016.01.009 |
0.308 |
|
| 2015 |
McElroy SL, Crow S, Blom TJ, Biernacka JM, Winham SJ, Geske J, Cuellar-Barboza AB, Bobo WV, Prieto ML, Veldic M, Mori N, Seymour LR, Bond DJ, Frye MA. Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder. Journal of Affective Disorders. 191: 216-221. PMID 26682490 DOI: 10.1016/J.Jad.2015.11.010 |
0.306 |
|
| 2015 |
Kung S, Palmer BA, Lapid MI, Poppe KA, Alarcon RD, Frye MA. Screening for bipolar disorders: Clinical utilization of the Mood Disorders Questionnaire on an inpatient mood disorders unit. Journal of Affective Disorders. 188: 97-100. PMID 26344754 DOI: 10.1016/J.Jad.2015.08.060 |
0.305 |
|
| 2015 |
Post RM, Leverich GS, Kupka R, Keck PE, McElroy SL, Altshuler LL, Frye MA, Rowe M, Grunze H, Suppes T, Nolen WA. Increases in multiple psychiatric disorders in parents and grandparents of patients with bipolar disorder from the USA compared with The Netherlands and Germany. Psychiatric Genetics. PMID 26146875 DOI: 10.1097/Ypg.0000000000000093 |
0.306 |
|
| 2015 |
Ketter TA, Yang R, Frye MA. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder. Journal of Affective Disorders. 181: 87-91. PMID 25933099 DOI: 10.1016/j.jad.2015.04.012 |
0.327 |
|
| 2015 |
Kung S, Palmer BA, Lapid MI, Poppe KA, Alarcon RD, Frye MA. Screening for bipolar disorders: Clinical utilization of the Mood Disorders Questionnaire on an inpatient mood disorders unit Journal of Affective Disorders. 188: 97-100. DOI: 10.1016/j.jad.2015.08.060 |
0.306 |
|
| 2013 |
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, Post RM, Berk M, Goodwin GM, Sachs GS, Tondo L, Findling RL, Youngstrom EA, Tohen M, Undurraga J, ... ... Frye MA, et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. The American Journal of Psychiatry. 170: 1249-62. PMID 24030475 DOI: 10.1176/Appi.Ajp.2013.13020185 |
0.311 |
|
| 2013 |
McElroy SL, Crow S, Biernacka JM, Winham S, Geske J, Cuellar Barboza AB, Prieto ML, Chauhan M, Seymour LR, Mori N, Frye MA. Clinical phenotype of bipolar disorder with comorbid binge eating disorder. Journal of Affective Disorders. 150: 981-6. PMID 23742827 DOI: 10.1016/J.Jad.2013.05.024 |
0.303 |
|
| 2013 |
Frey BN, Andreazza AC, Houenou J, Jamain S, Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, et al. Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. The Australian and New Zealand Journal of Psychiatry. 47: 321-32. PMID 23411094 DOI: 10.1177/0004867413478217 |
0.308 |
|
| 2013 |
Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, Scott J, Ha K, Suppes T. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. The American Journal of Psychiatry. 170: 31-42. PMID 23223893 DOI: 10.1176/appi.ajp.2012.12030301 |
0.313 |
|
| 2013 |
Auger R, Das P, Cao H, Feeder S, Kashyap R, Frye M. Chronotype distribution in bipolar disorder and major depressive disorder in an in-patient sample at a tertiary care center Sleep Medicine. 14: e66. DOI: 10.1016/J.SLEEP.2013.11.126 |
0.314 |
|
| 2013 |
Frye M, Ketter T, Yang R, Calabrese J. A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder Value in Health. 16: A55-A56. DOI: 10.1016/J.JVAL.2013.03.1552 |
0.314 |
|
| 2012 |
Gitlin M, Frye MA. Maintenance therapies in bipolar disorders. Bipolar Disorders. 14: 51-65. PMID 22510036 DOI: 10.1111/j.1399-5618.2012.00992.x |
0.318 |
|
| 2012 |
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Nolen WA, Rowe M, Kupka RW, Grunze H, Goodwin FK. Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. The Journal of Clinical Psychiatry. 73: 924-30. PMID 22480597 DOI: 10.4088/Jcp.11M07396 |
0.301 |
|
| 2011 |
Frye MA, Ha K, Kanba S, Kato T, McElroy SL, Özerdem A, Vázquez G, Vieta E. International consensus group on depression prevention in bipolar disorder. The Journal of Clinical Psychiatry. 72: 1295-310. PMID 22075097 DOI: 10.4088/JCP.10123co1c |
0.316 |
|
| 2011 |
Shippee ND, Shah ND, Williams MD, Moriarty JP, Frye MA, Ziegenfuss JY. Differences in demographic composition and in work, social, and functional limitations among the populations with unipolar depression and bipolar disorder: results from a nationally representative sample. Health and Quality of Life Outcomes. 9: 90. PMID 21995725 DOI: 10.1186/1477-7525-9-90 |
0.346 |
|
| 2011 |
Frye MA. Clinical practice. Bipolar disorder--a focus on depression. The New England Journal of Medicine. 364: 51-9. PMID 21208108 DOI: 10.1056/NEJMcp1000402 |
0.314 |
|
| 2011 |
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes T, Keck PE, McElroy SL, Nolen WA, Kupka R, Grunze H, Walden J, Rowe M. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. International Clinical Psychopharmacology. 26: 96-106. PMID 21178634 DOI: 10.1097/Yic.0B013E3283409419 |
0.307 |
|
| 2011 |
McElroy SL, Frye MA, Hellemann G, Altshuler L, Leverich GS, Suppes T, Keck PE, Nolen WA, Kupka R, Post RM. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. Journal of Affective Disorders. 128: 191-8. PMID 20674033 DOI: 10.1016/J.Jad.2010.06.037 |
0.333 |
|
| 2011 |
Frye MA. Ask the Expert: Bipolar Disorder Focus. 9: 455-456. DOI: 10.1176/foc.9.4.foc455 |
0.303 |
|
| 2010 |
Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. The Journal of Clinical Psychiatry. 71: 1363-70. PMID 20673554 DOI: 10.4088/JCP.09m05900gry |
0.3 |
|
| 2010 |
Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. The American Journal of Psychiatry. 167: 708-15. PMID 20231325 DOI: 10.1176/Appi.Ajp.2009.09010105 |
0.335 |
|
| 2010 |
Suppes T, Hellemann G, Frye MA, McElroy S, Nolen W, Kupka R, Leverich G, Grunze H. Mixed depression in bipolar disorder : prevalence rate and clinical correlates during naturalistic follow up Bipolar Disorders. 12: 52-52. DOI: 10.1111/Bdi.12306_24 |
0.317 |
|
| 2010 |
Frye MA, Perugi G. Comorbidity in Bipolar Disorder: A Focus on Addiction and Anxiety Disorders Bipolar Disorder: Clinical and Neurobiological Foundations. 31-43. DOI: 10.1002/9780470661277.ch4 |
0.304 |
|
| 2009 |
Tye SJ, Frye MA, Lee KH. Disrupting disordered neurocircuitry: treating refractory psychiatric illness with neuromodulation. Mayo Clinic Proceedings. 84: 522-32. PMID 19483169 DOI: 10.1016/S0025-6196(11)60584-3 |
0.324 |
|
| 2009 |
Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T. Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. The American Journal of Psychiatry. 166: 164-72. PMID 19015231 DOI: 10.1176/Appi.Ajp.2008.08030322 |
0.305 |
|
| 2009 |
Frye MA. Treatment Guidelines for Acute Manic and Mixed Episodes of Bipolar Disorder Cns Spectrums. 14: 8-11. DOI: 10.1017/S1092852900004028 |
0.327 |
|
| 2008 |
Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biological Psychiatry. 63: 125-30. PMID 17543894 DOI: 10.1016/j.biopsych.2006.12.031 |
0.315 |
|
| 2007 |
Keck PE, Frye MA, Thase ME. Bipolar depression: best practices for the hospitalized patient. Cns Spectrums. 12: 1-13. PMID 17984859 DOI: 10.1017/S1092852900015844 |
0.33 |
|
| 2007 |
Suppes T, Kelly DI, Keck PE, McElroy SL, Altshuler LL, Mintz J, Frye MA, Nolen WA, Luckenbaugh DA, Post RM, Leverich GS, Kupka RW, Grunze H. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network. International Clinical Psychopharmacology. 22: 376-81. PMID 17917557 DOI: 10.1097/Yic.0B013E3281C55F63 |
0.305 |
|
| 2007 |
McDermott BE, Quanbeck CD, Frye MA. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest. Bipolar Disorders. 9: 536-40. PMID 17680926 DOI: 10.1111/j.1399-5618.2007.00346.x |
0.304 |
|
| 2007 |
Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye MA, Keck PE, McElroy SL, Grunze H, Post RM. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disorders. 9: 531-5. PMID 17680925 DOI: 10.1111/J.1399-5618.2007.00467.X |
0.318 |
|
| 2007 |
Dossett EC, Land AJ, Gitlin MJ, Frye MA. Lack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant bipolar I disorder. The Journal of Clinical Psychiatry. 68: 973-4. PMID 17592931 DOI: 10.4088/Jcp.V68N0624E |
0.321 |
|
| 2006 |
Post RM, Altshuler LL, Leverich GS, Frye MA, Nolen WA, Kupka RW, Suppes T, McElroy S, Keck PE, Denicoff KD, Grunze H, Walden J, Kitchen CM, Mintz J. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. The British Journal of Psychiatry : the Journal of Mental Science. 189: 124-31. PMID 16880481 DOI: 10.1192/bjp.bp.105.013045 |
0.334 |
|
| 2006 |
Keck PE, Mintz J, McElroy SL, Freeman MP, Suppes T, Frye MA, Altshuler LL, Kupka R, Nolen WA, Leverich GS, Denicoff KD, Grunze H, Duan N, Post RM. Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder. Biological Psychiatry. 60: 1020-2. PMID 16814257 DOI: 10.1016/J.Biopsych.2006.03.056 |
0.329 |
|
| 2006 |
Altshuler LL, Suppes T, Black DO, Nolen WA, Leverich G, Keck PE, Frye MA, Kupka R, McElroy SL, Grunze H, Kitchen CM, Post R. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. The American Journal of Psychiatry. 163: 313-5. PMID 16449487 DOI: 10.1176/Appi.Ajp.163.2.313 |
0.345 |
|
| 2005 |
Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. The American Journal of Psychiatry. 162: 1273-80. PMID 15994709 DOI: 10.1176/Appi.Ajp.162.7.1273 |
0.329 |
|
| 2005 |
Post RM, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Leverich GS, Kupka R, Nolen WA, Luckenbaugh DA, Walden J, Grunze H. Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder. The Journal of Clinical Psychiatry. 66: 370-4. PMID 15766304 DOI: 10.4088/Jcp.V66N0314 |
0.313 |
|
| 2004 |
Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE, Leverich GS, Post RM. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. The American Journal of Psychiatry. 161: 1447-54. PMID 15285972 DOI: 10.1176/Appi.Ajp.161.8.1447 |
0.339 |
|
| 2004 |
Frye MA, Gitlin MJ, Altshuler LL. Unmet needs in bipolar depression. Depression and Anxiety. 19: 199-208. PMID 15274168 DOI: 10.1002/da.20013 |
0.362 |
|
| 2004 |
Suppes T, McElroy SL, Keck PE, Altshuler L, Frye MA, Grunze H, Leverich GS, Nolen WA, Chisholm K, Dennehy EB, Post RM. Use of quetiapine in bipolar disorder: a case series with prospective evaluation. International Clinical Psychopharmacology. 19: 173-4. PMID 15107662 DOI: 10.1097/00004850-200405000-00010 |
0.319 |
|
| 2003 |
Post RM, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Keck PE, McElroy SL, Kupka R, Nolen WA, Grunze H, Walden J. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disorders. 5: 310-9. PMID 14525551 DOI: 10.1034/J.1399-5618.2003.00051.X |
0.304 |
|
| 2003 |
Keck PE, McElroy SL, Havens JR, Altshuler LL, Nolen WA, Frye MA, Suppes T, Denicoff KD, Kupka R, Leverich GS, Rush AJ, Post RM. Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Comprehensive Psychiatry. 44: 263-9. PMID 12923703 DOI: 10.1016/S0010-440X(03)00089-0 |
0.35 |
|
| 2003 |
Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. The Journal of Clinical Psychiatry. 64: 680-90; quiz 738-9. PMID 12823083 DOI: 10.4088/Jcp.V64N0610 |
0.316 |
|
| 2002 |
Suppes T, Chisholm KA, Dhavale D, Frye MA, Altshuler LL, McElroy SL, Keck PE, Nolen WA, Kupka R, Denicoff KD, Leverich GS, Rush AJ, Post RM. Tiagabine in treatment refractory bipolar disorder: a clinical case series. Bipolar Disorders. 4: 283-9. PMID 12479659 DOI: 10.1034/J.1399-5618.2002.01201.X |
0.323 |
|
| 2001 |
Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL, Rush AJ, Kupka R, Frye MA, Bickel M, Post RM. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders. 67: 45-59. PMID 11869752 |
0.301 |
|
| 2001 |
Altshuler L, Kiriakos L, Calcagno J, Goodman R, Gitlin M, Frye M, Mintz J. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. The Journal of Clinical Psychiatry. 62: 612-6. PMID 11561933 DOI: 10.4088/Jcp.V62N0807 |
0.3 |
|
| 2001 |
McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, Nolen WA, Kupka RW, Leverich GS, Rochussen JR, Rush AJ, Post RM. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. The American Journal of Psychiatry. 158: 420-6. PMID 11229983 DOI: 10.1176/Appi.Ajp.158.3.420 |
0.339 |
|
| 2000 |
McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biological Psychiatry. 47: 1025-33. PMID 10862801 DOI: 10.1016/S0006-3223(99)00316-9 |
0.315 |
|
| 1999 |
Frye MA, Denicoff KD, Bryan AL, Smith-Jackson EE, Ali SO, Luckenbaugh D, Leverich GS, Post RM. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients. The American Journal of Psychiatry. 156: 1909-14. PMID 10588404 DOI: 10.1176/Ajp.156.12.1909 |
0.311 |
|
| 1999 |
Goldstein TR, Frye MA, Denicoff KD, Smith-Jackson E, Leverich GS, Bryan AL, Ali SO, Post RM. Antidepressant discontinuation-related mania: critical prospective observation and theoretical implications in bipolar disorder. The Journal of Clinical Psychiatry. 60: 563-7; quiz 568-9. PMID 10485646 |
0.301 |
|
| 1999 |
Suppes T, Brown ES, McElroy SL, Keck PE, Nolen W, Kupka R, Frye M, Denicoff KD, Altshuler L, Leverich GS, Post RM. Lamotrigine for the treatment of bipolar disorder: a clinical case series. Journal of Affective Disorders. 53: 95-8. PMID 10363672 DOI: 10.1016/S0165-0327(98)00077-9 |
0.319 |
|
| 1998 |
Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Corá-Locatelli G, Post RM. Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. Journal of Affective Disorders. 48: 91-104. PMID 9543198 DOI: 10.1016/S0165-0327(97)00160-2 |
0.309 |
|
| Show low-probability matches. |